Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Verily Life Sciences Coronavirus Test Gets FDA Emergency Use Authorization

Verily Life Sciences Coronavirus Test Gets FDA Emergency Use Authorization

Sep 09, 2020
|
staff reporter

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Verily Life Science's molecular SARS-CoV-2 test.

The Verily COVID-19 RT-PCR Test is designed to detect the ORF1ab, N, and S genes of SARS-CoV-2 in upper respiratory specimens and can be used with pooled samples containing up to 12 individual specimens collected by healthcare providers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Plans Out

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

CovidNudge Numbers

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Sep
23
Featured Webinar

Fluorescent Amplification for Next Generation Sequencing Library Preparation: A Streamlined Workflow to Improve NGS Quality Control Testing

Sponsored by
Beckman Coulter

This webinar will discuss a streamlined library preparation method for next-generation sequencing (NGS) that improves quality control testing capability while reducing the total number of steps compared to conventional multiplexed library workflows.

Sep
24
Featured Webinar

New Insights Underscore the Need to Identify NTRK Fusions in Childhood Tumors

Sponsored by
ArcherDX

NTRK fusions are oncogenic drivers in a variety of tumors.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
08
Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

What's Popular?

In Molecular Diagnostics

  1. FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results

    Premium

  2. Illumina's Stock Falls 9 Percent on Grail Acquisition Rumors

  3. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  4. Genetics Testing Firm Prenetics Receives $15M Investment From Apis Partners, Alibaba

  5. Grail Plans Additional Liquid Biopsy Tests for Cancer Detection, Monitoring

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.